CX3CR1 and type 2 diabetes mellitus: This signaling pathway modulates adipose tissue inflammation and insulin resistance in obese mice through the recruitment of adipose tissue macrophages and M1/M2 polarization, and therapeutics targeting the CX3CL1-CX3CR1 system may be beneficial for treating type 2 diabetes (64).